• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性神经性疼痛患者静脉注射氯胺酮治疗成败的预测因素。

Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain.

作者信息

Gargori Nezar M B, Alahwal Hazem, Vacheron Charles-Herve, Alam Farouq Mohammad A

机构信息

Department of Anesthesia and Intensive Care, Faculty of Medicine, Abdulaziz University, Jeddah, Western Region, Kingdom of Saudi Arabia.

Hospices Civils de Lyon, Lyon, Auverange Rhone Alpes, France.

出版信息

Saudi J Anaesth. 2023 Jul-Sep;17(3):340-348. doi: 10.4103/sja.sja_737_22. Epub 2023 Jun 22.

DOI:10.4103/sja.sja_737_22
PMID:37601528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10435804/
Abstract

BACKGROUND

Intravenous (IV) ketamine is used for chronic neuropathic pain refractory to other treatments. Administration of such a medication requires high-cost services while the result is not always satisfactory with a significant percentage of failure. Success and failure are related to some factors.

METHOD

In this study, we aim to point the most responsive disease category to IV ketamine and the predictive factors for successful and failed treatment. Two hundred and sixty-nine patients out of 371 were included. Demographic, clinical, and therapy-related variables were retrospectively collected and then statistically analyzed using various descriptive and inferential methods. A few descriptive statistics are obtained for the variables depending on their nature (e.g., percentages for qualitative variables and means for quantitative variables). Furthermore, several inferential methods are considered to address some statistical points of interest, including, but not limited to, odds ratio interpretations via logistic regression as well as association and correlation analyses.

RESULTS

A significant association was found between the presence of intermittent pain pattern as well as the pain of chronic primary category and favorable response to IV ketamine while the history of previous analgesic interventions was significantly associated with a negative response.

CONCLUSION

The identified factors can be used to prospectively study the efficacy of ketamine using selection criteria based on the observed results in our study to re-evaluate the percentage of responsiveness according to these new parameters.

摘要

背景

静脉注射氯胺酮用于治疗对其他治疗无效的慢性神经性疼痛。使用这种药物需要高昂的医疗服务成本,而且治疗结果并不总是令人满意,失败率相当高。治疗的成功与失败与一些因素有关。

方法

在本研究中,我们旨在指出对静脉注射氯胺酮反应最敏感的疾病类别以及治疗成功与失败的预测因素。从371名患者中纳入了269名。回顾性收集人口统计学、临床和治疗相关变量,然后使用各种描述性和推断性方法进行统计分析。根据变量的性质获得一些描述性统计量(例如,定性变量的百分比和定量变量的均值)。此外,考虑了几种推断性方法来解决一些感兴趣的统计问题,包括但不限于通过逻辑回归进行比值比解释以及关联和相关性分析。

结果

发现间歇性疼痛模式以及慢性原发性疼痛的存在与对静脉注射氯胺酮的良好反应之间存在显著关联,而既往镇痛干预史与负面反应显著相关。

结论

根据我们研究中观察到的结果,所确定的因素可用于前瞻性研究氯胺酮的疗效,使用选择标准重新评估根据这些新参数的反应率。

相似文献

1
Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain.慢性神经性疼痛患者静脉注射氯胺酮治疗成败的预测因素。
Saudi J Anaesth. 2023 Jul-Sep;17(3):340-348. doi: 10.4103/sja.sja_737_22. Epub 2023 Jun 22.
2
Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study.氯胺酮输注疗法对韩国神经性疼痛患者的镇痛效果:一项为期2周的开放标签、非对照研究。
Curr Ther Res Clin Exp. 2010 Apr;71(2):93-104. doi: 10.1016/j.curtheres.2010.04.001.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.静脉注射氯胺酮试验作为阿片类药物暴露的持续性疼痛患者的预测反应工具。
J Pain Symptom Manage. 2009 Apr;37(4):698-708. doi: 10.1016/j.jpainsymman.2008.03.018. Epub 2008 Sep 11.
5
6
Analgesic Effect of Intraoperative Intravenous S-Ketamine in Opioid-Naïve Patients After Major Lumbar Fusion Surgery Is Temporary and Not Dose-Dependent: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.全麻下静脉注射 S-氯胺酮对初次接受腰椎融合术的阿片类药物未使用者的镇痛效果是暂时的,且与剂量无关:一项随机、双盲、安慰剂对照的临床试验。
Anesth Analg. 2021 Jan;132(1):69-79. doi: 10.1213/ANE.0000000000004729.
7
The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.多日(10-14 天)亚麻醉剂量 IV 氯胺酮输注治疗难治性慢性疼痛的效果。
Pain Manag. 2022 Apr;12(3):337-346. doi: 10.2217/pmt-2021-0064. Epub 2021 Sep 16.
8
Perioperative intravenous ketamine for acute postoperative pain in adults.围手术期静脉注射氯胺酮用于成人术后急性疼痛
Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012033. doi: 10.1002/14651858.CD012033.pub4.
9
The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain.静脉注射氯胺酮试验:一种用于神经性疼痛中口服右美沙芬治疗的预测性反应工具。
Anesth Analg. 2004 Dec;99(6):1753-1759. doi: 10.1213/01.ANE.0000136953.11583.7B.
10
Ketamine in chronic pain management: an evidence-based review.氯胺酮在慢性疼痛管理中的应用:一项基于证据的综述。
Anesth Analg. 2003 Dec;97(6):1730-1739. doi: 10.1213/01.ANE.0000086618.28845.9B.

本文引用的文献

1
Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia.静脉注射氯胺酮治疗纤维肌痛的系统评价
Ochsner J. 2021 Winter;21(4):387-394. doi: 10.31486/toj.21.0038.
2
Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.滥用氯胺酮作为速效抗抑郁药的相关风险。
Neurosci Bull. 2016 Dec;32(6):557-564. doi: 10.1007/s12264-016-0081-2. Epub 2016 Nov 22.
3
Cerebral Cortical Thickness in Chronic Pain Due to Knee Osteoarthritis: The Effect of Pain Duration and Pain Sensitization.膝关节骨关节炎所致慢性疼痛中的大脑皮质厚度:疼痛持续时间和疼痛敏化的影响
PLoS One. 2016 Sep 22;11(9):e0161687. doi: 10.1371/journal.pone.0161687. eCollection 2016.
4
An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.疼痛与抑郁之间的复杂关系:临床相关性、共激活因素和治疗靶点。
Expert Opin Ther Targets. 2014 Feb;18(2):159-76. doi: 10.1517/14728222.2014.855720. Epub 2013 Dec 3.
5
Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study.氯胺酮和吗啡对慢性疼痛患者下行性疼痛调制的影响:一项随机安慰剂对照交叉概念验证研究。
Br J Anaesth. 2013 Jun;110(6):1010-6. doi: 10.1093/bja/aes578. Epub 2013 Feb 5.
6
Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care.氯胺酮静脉持续输注在难治性癌痛中的镇痛效果:姑息治疗中临床研究的考虑因素。
J Palliat Med. 2012 Mar;15(3):287-93. doi: 10.1089/jpm.2011.0353. Epub 2012 Feb 15.
7
Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.门诊氯胺酮输注治疗难治性慢性疼痛综合征的疗效:一项 5 年回顾性分析。
Pain Med. 2012 Feb;13(2):263-9. doi: 10.1111/j.1526-4637.2011.01241.x. Epub 2011 Sep 21.
8
Ketamine in pain management.氯胺酮在疼痛管理中的应用。
Adv Psychosom Med. 2011;30:139-161. doi: 10.1159/000324071. Epub 2011 Apr 19.
9
Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial.短期 S-氯胺酮输注治疗纤维肌痛疼痛无长期镇痛作用:一项随机、前瞻性、双盲、活性安慰剂对照试验。
Eur J Pain. 2011 Oct;15(9):942-9. doi: 10.1016/j.ejpain.2011.03.008. Epub 2011 Apr 11.
10
Taming the ketamine tiger. 1965.驯服氯胺酮这只老虎。1965 年。
Anesthesiology. 2010 Sep;113(3):678-84. doi: 10.1097/ALN.0b013e3181ed09a2.